Arty Rajendra > Osborne Clarke LLP > London, England > Lawyer Profile

Continuing to expand its patent practice, the ‘switched on and collaborative’ team at Osborne Clarke LLP counts notable biotech and pharmaceutical clients among its key roster of clients, handling revocation and infringement proceedings on a global scale alongside technical commercial transactional mandates. Arty Rajendra heads up the group, fielding a strong practice on the SEP and FRAND disputes side, while Will James possesses a wealth of experience across the life sciences, electronics, and medical device sectors. Tim Harris drives life sciences, pharmaceutical, and biotech mandates for the team, and Trevor Crosse utilises his background in microbiology and immunology to handle blockbuster drugs and other technically complex products.

Tech-savvy Osborne Clarke LLP covers a comprehensive range of IP mandates, from trade mark and copyright litigation through to managing database rights and global portfolios. Experienced litigator Arty Rajendra advises notable clients on the full gamut of IP issues, with particular strengths in the trade mark sphere. Other key contacts include Robert Guthrie, another capable litigator who routinely represents clients in court in relation to a variety of trade mark and copyright issues, and Richard May, who leads the firm’s consumer products group with his experience in all facets of brand protection.